Literature DB >> 1401059

Combined enzyme defect of mitochondrial fatty acid oxidation.

S Jackson1, R S Kler, K Bartlett, H Briggs, L A Bindoff, M Pourfarzam, D Gardner-Medwin, D M Turnbull.   

Abstract

A young girl presented with recurrent episodes of muscle weakness culminating in a severe attack of generalized muscle weakness. In the muscle mitochondria from the patient there was an abnormal pattern of intermediates of beta-oxidation with an accumulation of 3-hydroxyacyl- and 2-enoyl-CoA and carnitine esters, and 3-oxoacylcarnitines. There was low activity of long-chain 3-hydroxyacyl-CoA dehydrogenase in mitochondria from all tissues. The activity of long-chain 2-enoyl-CoA hydratase was low in muscle mitochondria and 3-oxoacyl-CoA thiolase activity measured with 3-oxohexadecanoyl-CoA as substrate was low in fibroblast, muscle, and cardiac mitochondria but only partial deficiency was present when the activity was measured with 3-oxooctanoyl-CoA. The activity of the long-chain 3-hydroxyacyl-CoA dehydrogenase and long-chain 3-oxoacyl-CoA thiolase in fibroblasts from the patient's parents was intermediate between those of controls and the patient. The patient has a combined defect of the long-chain 3-hydroxyacyl-CoA dehydrogenase, long-chain 3-oxoacyl-CoA thiolase, and long-chain 2-enoyl-CoA hydratase which appears to be inherited in an autosomal recessive manner. This suggests there is a multifunctional enzyme catalyzing these activities in human mitochondria and that this enzyme is deficient in our patient.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1401059      PMCID: PMC443162          DOI: 10.1172/JCI115983

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

1.  Progressive neuropathy and recurrent myoglobinuria in a child with long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency.

Authors:  C Dionisi Vici; A B Burlina; E Bertini; C Bachmann; M R Mazziotta; F Zacchello; G Sabetta; D E Hale
Journal:  J Pediatr       Date:  1991-05       Impact factor: 4.406

2.  Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: identification of a new inborn error of mitochondrial fatty acid beta-oxidation.

Authors:  R J Wanders; L IJlst; A H van Gennip; C Jakobs; J P de Jager; L Dorland; F J van Sprang; M Duran
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

3.  Molecular basis of medium chain acyl-coenzyme A dehydrogenase deficiency. An A to G transition at position 985 that causes a lysine-304 to glutamate substitution in the mature protein is the single prevalent mutation.

Authors:  I Yokota; Y Indo; P M Coates; K Tanaka
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

4.  Human liver long-chain 3-hydroxyacyl-coenzyme A dehydrogenase is a multifunctional membrane-bound beta-oxidation enzyme of mitochondria.

Authors:  K Carpenter; R J Pollitt; B Middleton
Journal:  Biochem Biophys Res Commun       Date:  1992-03-16       Impact factor: 3.575

5.  Molecular characterization of inherited medium-chain acyl-CoA dehydrogenase deficiency.

Authors:  D P Kelly; A J Whelan; M L Ogden; R Alpers; Z F Zhang; G Bellus; N Gregersen; L Dorland; A W Strauss
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

6.  Skeletal muscle mitochondrial beta-oxidation. A study of the products of oxidation of [U-14C]hexadecanoate by h.p.l.c. using continuous on-line radiochemical detection.

Authors:  N J Watmough; A K Bhuiyan; K Bartlett; H S Sherratt; D M Turnbull
Journal:  Biochem J       Date:  1988-07-15       Impact factor: 3.857

7.  The measurement of carnitine and acyl-carnitines: application to the investigation of patients with suspected inherited disorders of mitochondrial fatty acid oxidation.

Authors:  A K Bhuiyan; S Jackson; D M Turnbull; A Aynsley-Green; J V Leonard; K Bartlett
Journal:  Clin Chim Acta       Date:  1992-05-15       Impact factor: 3.786

8.  Hypoglycemia, hepatic dysfunction, muscle weakness, cardiomyopathy, free carnitine deficiency and long-chain acylcarnitine excess responsive to medium chain triglyceride diet.

Authors:  A M Glasgow; A G Engel; D M Bier; L W Perry; M Dickie; J Todaro; B I Brown; M F Utter
Journal:  Pediatr Res       Date:  1983-05       Impact factor: 3.756

9.  Glutaric acidemia type II: heterogeneity of clinical and biochemical phenotypes.

Authors:  J P Loehr; S I Goodman; F E Frerman
Journal:  Pediatr Res       Date:  1990-03       Impact factor: 3.756

10.  Quantitation of acyl-CoA and acylcarnitine esters accumulated during abnormal mitochondrial fatty acid oxidation.

Authors:  R S Kler; S Jackson; K Bartlett; L A Bindoff; S Eaton; M Pourfarzam; F E Frerman; S I Goodman; N J Watmough; D M Turnbull
Journal:  J Biol Chem       Date:  1991-12-05       Impact factor: 5.157

View more
  28 in total

Review 1.  Acute fatty liver of pregnancy: an update on pathogenesis and clinical implications.

Authors:  Jamal-A Ibdah
Journal:  World J Gastroenterol       Date:  2006-12-14       Impact factor: 5.742

2.  Molecular characterization of mitochondrial trifunctional protein deficiency: formation of the enzyme complex is important for stabilization of both alpha- and beta-subunits.

Authors:  S Ushikubo; T Aoyama; T Kamijo; R J Wanders; P Rinaldo; J Vockley; T Hashimoto
Journal:  Am J Hum Genet       Date:  1996-05       Impact factor: 11.025

3.  Cardioprotective GLP-1 metabolite prevents ischemic cardiac injury by inhibiting mitochondrial trifunctional protein-α.

Authors:  M Ahsan Siraj; Dhanwantee Mundil; Sanja Beca; Abdul Momen; Eric A Shikatani; Talat Afroze; Xuetao Sun; Ying Liu; Siavash Ghaffari; Warren Lee; Michael B Wheeler; Gordon Keller; Peter Backx; Mansoor Husain
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

4.  Common missense mutation G1528C in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Characterization and expression of the mutant protein, mutation analysis on genomic DNA and chromosomal localization of the mitochondrial trifunctional protein alpha subunit gene.

Authors:  L IJlst; J P Ruiter; J M Hoovers; M E Jakobs; R J Wanders
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

5.  Retinal dystrophy in long chain 3-hydroxy-acyl-coA dehydrogenase deficiency.

Authors:  I Schrijver-Wieling; G H van Rens; D Wittebol-Post; J A Smeitink; J P de Jager; H B de Klerk; G H van Lith
Journal:  Br J Ophthalmol       Date:  1997-04       Impact factor: 4.638

6.  Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: high frequency of the G1528C mutation with no apparent correlation with the clinical phenotype.

Authors:  L Ijlst; S Uskikubo; T Kamijo; T Hashimoto; J P Ruiter; J B de Klerk; R J Wanders
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

7.  Lack of mitochondrial trifunctional protein in mice causes neonatal hypoglycemia and sudden death.

Authors:  J A Ibdah; H Paul; Y Zhao; S Binford; K Salleng; M Cline; D Matern; M J Bennett; P Rinaldo; A W Strauss
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

8.  Mild trifunctional protein deficiency is associated with progressive neuropathy and myopathy and suggests a novel genotype-phenotype correlation.

Authors:  J A Ibdah; I Tein; C Dionisi-Vici; M J Bennett; L IJlst; B Gibson; R J Wanders; A W Strauss
Journal:  J Clin Invest       Date:  1998-09-15       Impact factor: 14.808

9.  Rhabdomyolysis and acute encephalopathy in late onset medium chain acyl-CoA dehydrogenase deficiency.

Authors:  W Ruitenbeek; P J Poels; D M Turnbull; B Garavaglia; R A Chalmers; R W Taylor; F J Gabreëls
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-02       Impact factor: 10.154

10.  Mitochondrial trifunctional protein deficiency. Catalytic heterogeneity of the mutant enzyme in two patients.

Authors:  T Kamijo; R J Wanders; J M Saudubray; T Aoyama; A Komiyama; T Hashimoto
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.